DNA storage leaves the lab: Atlas launches the Eon 100, a pill-sized capsule that replaces a thousand tape cartridges

DNA storage leaves the lab: Atlas launches the Eon 100, a pill-sized capsule that replaces a thousand tape cartridges

Atlas Data Storage has introduced the first commercial data archiving service in synthetic DNA—the Atlas Eon 100. According to the company, one capsule contains a density comparable to a thousand tape cartridges, with a storage life estimated at "millennia." The solution is designed for AI model archives, digital legacy, and corporate data that needs to be preserved for generations.

From Experiments to Product: DNA Archiving Enters Industrial Mode

Until recently, DNA data storage existed only in the realm of scientific experiments, and publications about record-breaking storage densities were seen as demonstrations of future technologies. But the startup Atlas Data Storage is announcing its move beyond the laboratory: the Atlas Eon 100 service is positioned as the world's first scalable commercial solution for long-term DNA archiving.

Company founder Bill Bagnai emphasizes: Atlas is the only company that delivers industrial-grade DNA products. The launch of Eon 100 is the culmination of more than ten years of work at the intersection of bioengineering, computer science, and materials science.

The service is aimed at clients who need to preserve valuable data for decades and even centuries to come: large AI models, digital heritage, unique corporate archives, and scientific data.

DNA storage leaves the lab: Atlas launches the Eon 100, a pill-sized capsule that replaces a thousand tape cartridges

The main argument is durability: DNA as an “eternal carrier”

Atlas emphasizes that the Eon 100 DNA capsules are capable of preserving data for millennia without being overwritten. This is a major contrast to traditional corporate tape archives, where the media is recommended to be completely replaced every 7–10 years, under strict temperature and humidity control.

Eon 100 capsules are considered stable at temperatures up to 40°C, making them suitable for long-term storage in conditions where magnetic tape degrades quickly.

An advantage Atlas highlights is that copying DNA from a carrier is simpler, faster, and potentially cheaper than creating backup tape archives.

Storage density: 1 capsule ≈ 1000 tape cartridges

The main thing that attracted the industry's attention was density.

According to Atlas, the Eon 100 can store approximately 60 petabytes of data in a volume of approximately 60 cubic inches—less than one liter. Promotional materials depict this capacity as several trays containing capsules roughly the size of a pill.

The company claims this DNA storage is a thousand times denser than LTO-10 cartridges. In other words, one capsule replaces the volume of traditional tapes, equivalent to an entire corporate archive.

This ratio is impossible for classical magnetic media and underscores the key idea: DNA archives are not just an alternative, but a new physical density limit.

What's inside: Synthetic DNA from Twist Bioscience

The data is stored using synthetic DNA supplied by Twist Bioscience, one of the most prominent players in the biosynthesis market. The company has previously been involved in several DNA storage research projects, including a collaboration with Microsoft.

The Eon 100 uses an encoding scheme that converts digital information into nucleotide sequences. The DNA is then synthesized, protected in a stable capsule, and can be stored virtually indefinitely at room temperature.
Reading occurs in the reverse order: the molecules are extracted, sequenced, and decoded into the original data.

The principle has long been studied, but this is the first time that it has been brought to industrial scale—a key turning point.

Why Atlas is entering the market now

The launch of the Eon 100 is a logical snapshot of current technological trends:

the volumes of data from large AI models are growing rapidly;
archives are becoming more expensive and require complex infrastructure;
Companies are looking for ways to preserve content “in the long run” without constantly rewriting it;

Traditional media have reached their density limits.

AI models are one of the main reasons for the emergence of products like Eon 100: large LLM archives require not only space but also long-term storage.

Limitations: This is a corporate solution, not a consumer one.

Despite the loud announcements and demonstrations at the AIMA conference in Baltimore, the Eon 100 is not available for direct purchase. Only an application form is available on the website. Pricing and pricing are not disclosed. This is a typical strategy for technologies still in the corporate research phase.

Eon 100 is aimed at:

state archives,
large AI companies,
media storage,
financial and legal structures,
organizations that preserve content for decades to come.

The consumer market here is still just beginning to emerge. Atlas is targeting corporate budgets—and that makes sense, given the cost of synthetic DNA.

The Future of DNA Storage: From Pills to “Eternal” Home Archives

The commercialization of DNA archives is just beginning. It's already emerged from the purely academic phase—that's a fact. But the road to mass-market devices is incredibly long.

Analytical assumption: even if the technological roadmap is accelerated, truly consumer-grade solutions will not appear for at least 10 years. The cost of DNA synthesis is too high, the infrastructure is developing too slowly, and sequencing is too expensive.

But the image of the future has already been drawn:
laptop with a slot for a DNA capsule;
personal archive of 60+ petabytes;
“eternal” capsule with digital memory for life;
family archives, calculated for 100-200 years ahead.

It's a beautiful concept today, but the Atlas Eon 100 shows that the transition to practice has already begun.


Atlas Eon 100 is the first step towards the era of ultra-long-term digital heritage.
A pill-sized capsule capable of replacing a thousand tape cartridges and storing data for millennia is changing the very architecture of archives.

While this is currently a tool for corporations, the very fact that a commercial product in the field of DNA storage has emerged means that the technology is no longer “future research” – it is becoming part of the data infrastructure for decades to come.
Written by Ethan Blake
Independent researcher, fintech consultant, and market analyst.

December 09, 2025

Join us. Our Telegram: @forexturnkey
All to the point, no ads. A channel that doesn't tire you out, but pumps you up.
FX24

Author’s Posts